Expression of survivin in bladder cancer cell lines using quantitative real-time polymerase chain reaction

Kee Thai Kiu, Thomas I S Hwang, Hsiao Yen Hsieh, Cheng Huang Shen, Yuan Hung Wang, Guang Dar Juang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Previous studies have reported that survivin expression is significantly associated with various malignancies including bladder cancer. However, the relationship between the expression of survivin and the tumor stage and grade of bladder cancer still require further study. Methods: To determine whether survivin plays a role in the differentiation of bladder cancer cells, we conducted a preliminary study to examine the expression of survivin in bladder cancer cell lines. Results: In this study, we observed that the gene expression fold changes of survivin ranged from 3.2 to 16.7 in various tumor grades (G1-G4) of bladder cancer cell lines, which were higher than that in normal human urothelial cell line. With the worse differentiation of bladder cancer cell lines, the gene expression fold changes of survivin increased significantly (3.2-fold in RT4, 5.8-fold in 5637, 6.6-fold in T24, and 16.7-fold in HT1197). In addition, we observed different genotypes among various cell lines (C/C in HUC4449, C/G in RT4, C/G in 5637, G/G in T24, and C/C in HT1197). The relationship between survivin -31 C/G polymorphism and various bladder cancer cell lines was non-significant. However, the overexpression of survivin may be associated with aggressive features of bladder cancer. Conclusion: Our findings suggest that survivin could be a potential therapeutic target through the inhibition of cell proliferation in bladder cancer.

Original languageEnglish
Pages (from-to)19-21
Number of pages3
JournalUrological Science
Volume25
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Urinary Bladder Neoplasms
Real-Time Polymerase Chain Reaction
Cell Line
Gene Expression
Neoplasms
Genotype
Cell Proliferation

Keywords

  • Bladder cancer
  • Cell lines
  • Gene expression
  • Polymorphism
  • Survivin

ASJC Scopus subject areas

  • Urology

Cite this

Expression of survivin in bladder cancer cell lines using quantitative real-time polymerase chain reaction. / Kiu, Kee Thai; Hwang, Thomas I S; Hsieh, Hsiao Yen; Shen, Cheng Huang; Wang, Yuan Hung; Juang, Guang Dar.

In: Urological Science, Vol. 25, No. 1, 2014, p. 19-21.

Research output: Contribution to journalArticle

Kiu, Kee Thai ; Hwang, Thomas I S ; Hsieh, Hsiao Yen ; Shen, Cheng Huang ; Wang, Yuan Hung ; Juang, Guang Dar. / Expression of survivin in bladder cancer cell lines using quantitative real-time polymerase chain reaction. In: Urological Science. 2014 ; Vol. 25, No. 1. pp. 19-21.
@article{3dd65f31d3e2474d9e9d2d9176bea0a0,
title = "Expression of survivin in bladder cancer cell lines using quantitative real-time polymerase chain reaction",
abstract = "Objective: Previous studies have reported that survivin expression is significantly associated with various malignancies including bladder cancer. However, the relationship between the expression of survivin and the tumor stage and grade of bladder cancer still require further study. Methods: To determine whether survivin plays a role in the differentiation of bladder cancer cells, we conducted a preliminary study to examine the expression of survivin in bladder cancer cell lines. Results: In this study, we observed that the gene expression fold changes of survivin ranged from 3.2 to 16.7 in various tumor grades (G1-G4) of bladder cancer cell lines, which were higher than that in normal human urothelial cell line. With the worse differentiation of bladder cancer cell lines, the gene expression fold changes of survivin increased significantly (3.2-fold in RT4, 5.8-fold in 5637, 6.6-fold in T24, and 16.7-fold in HT1197). In addition, we observed different genotypes among various cell lines (C/C in HUC4449, C/G in RT4, C/G in 5637, G/G in T24, and C/C in HT1197). The relationship between survivin -31 C/G polymorphism and various bladder cancer cell lines was non-significant. However, the overexpression of survivin may be associated with aggressive features of bladder cancer. Conclusion: Our findings suggest that survivin could be a potential therapeutic target through the inhibition of cell proliferation in bladder cancer.",
keywords = "Bladder cancer, Cell lines, Gene expression, Polymorphism, Survivin",
author = "Kiu, {Kee Thai} and Hwang, {Thomas I S} and Hsieh, {Hsiao Yen} and Shen, {Cheng Huang} and Wang, {Yuan Hung} and Juang, {Guang Dar}",
year = "2014",
doi = "10.1016/j.urols.2013.11.002",
language = "English",
volume = "25",
pages = "19--21",
journal = "Urological Science",
issn = "1879-5226",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Expression of survivin in bladder cancer cell lines using quantitative real-time polymerase chain reaction

AU - Kiu, Kee Thai

AU - Hwang, Thomas I S

AU - Hsieh, Hsiao Yen

AU - Shen, Cheng Huang

AU - Wang, Yuan Hung

AU - Juang, Guang Dar

PY - 2014

Y1 - 2014

N2 - Objective: Previous studies have reported that survivin expression is significantly associated with various malignancies including bladder cancer. However, the relationship between the expression of survivin and the tumor stage and grade of bladder cancer still require further study. Methods: To determine whether survivin plays a role in the differentiation of bladder cancer cells, we conducted a preliminary study to examine the expression of survivin in bladder cancer cell lines. Results: In this study, we observed that the gene expression fold changes of survivin ranged from 3.2 to 16.7 in various tumor grades (G1-G4) of bladder cancer cell lines, which were higher than that in normal human urothelial cell line. With the worse differentiation of bladder cancer cell lines, the gene expression fold changes of survivin increased significantly (3.2-fold in RT4, 5.8-fold in 5637, 6.6-fold in T24, and 16.7-fold in HT1197). In addition, we observed different genotypes among various cell lines (C/C in HUC4449, C/G in RT4, C/G in 5637, G/G in T24, and C/C in HT1197). The relationship between survivin -31 C/G polymorphism and various bladder cancer cell lines was non-significant. However, the overexpression of survivin may be associated with aggressive features of bladder cancer. Conclusion: Our findings suggest that survivin could be a potential therapeutic target through the inhibition of cell proliferation in bladder cancer.

AB - Objective: Previous studies have reported that survivin expression is significantly associated with various malignancies including bladder cancer. However, the relationship between the expression of survivin and the tumor stage and grade of bladder cancer still require further study. Methods: To determine whether survivin plays a role in the differentiation of bladder cancer cells, we conducted a preliminary study to examine the expression of survivin in bladder cancer cell lines. Results: In this study, we observed that the gene expression fold changes of survivin ranged from 3.2 to 16.7 in various tumor grades (G1-G4) of bladder cancer cell lines, which were higher than that in normal human urothelial cell line. With the worse differentiation of bladder cancer cell lines, the gene expression fold changes of survivin increased significantly (3.2-fold in RT4, 5.8-fold in 5637, 6.6-fold in T24, and 16.7-fold in HT1197). In addition, we observed different genotypes among various cell lines (C/C in HUC4449, C/G in RT4, C/G in 5637, G/G in T24, and C/C in HT1197). The relationship between survivin -31 C/G polymorphism and various bladder cancer cell lines was non-significant. However, the overexpression of survivin may be associated with aggressive features of bladder cancer. Conclusion: Our findings suggest that survivin could be a potential therapeutic target through the inhibition of cell proliferation in bladder cancer.

KW - Bladder cancer

KW - Cell lines

KW - Gene expression

KW - Polymorphism

KW - Survivin

UR - http://www.scopus.com/inward/record.url?scp=84896542874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896542874&partnerID=8YFLogxK

U2 - 10.1016/j.urols.2013.11.002

DO - 10.1016/j.urols.2013.11.002

M3 - Article

AN - SCOPUS:84896542874

VL - 25

SP - 19

EP - 21

JO - Urological Science

JF - Urological Science

SN - 1879-5226

IS - 1

ER -